AbbVie Inc.ABBVNYSE
Loading
Operating Income ScalingExpanding
Percentile Rank100
3Y CAGR+5.4%
5Y CAGR+13.3%
Year-over-Year Change
Profit from core business operations before interest and taxes
3Y CAGR
+5.4%/yr
vs +29.8%/yr prior
5Y CAGR
+13.3%/yr
Recent deceleration
Acceleration
-24.4pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.9x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $21.21B | +132.2% |
| 2024 | $9.14B | -28.4% |
| 2023 | $12.76B | -29.6% |
| 2022 | $18.12B | +1.1% |
| 2021 | $17.92B | +57.7% |
| 2020 | $11.36B | -12.5% |
| 2019 | $12.98B | +103.4% |
| 2018 | $6.38B | -33.1% |
| 2017 | $9.54B | +2.2% |
| 2016 | $9.34B | - |